Patient-reported outcomes in breast cancer FDA drug labels and review documents

BACKGROUND: Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast cancer treatments. The United States Food and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Patient Rep Outcomes
Main Authors: Hong, Kyungwan, Majercak, Kayleigh R., Villalonga-Olives, Ester, Perfetto, Eleanor M.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2021
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8060367/
https://ncbi.nlm.nih.gov/pubmed/33881661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41687-021-00308-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki